期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CURRENT GENE THERAPY LetPub Score 5.1
50 ratings
Rate
Reputation 6.3 Influence 3.8 Speed 7.0 | ||||||||||||||||||||||||||||||||
期刊簡稱 | CURR GENE THER | ||||||||||||||||||||||||||||||||
ISSN | 1566-5232 | ||||||||||||||||||||||||||||||||
E-ISSN | 1875-5631 | ||||||||||||||||||||||||||||||||
h-index | 65 | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 2.60%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | http://benthamscience.com/journal/index.php?journalID=cgt | ||||||||||||||||||||||||||||||||
在線稿件提交 | http://bsp-cms.eurekaselect.com/index.php/CGT | ||||||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||||||
出版商 | Bentham Science Publishers B.V. | ||||||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||||||||||
創刊年 | 2001 | ||||||||||||||||||||||||||||||||
每年文章數 | 31每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 5.88% | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1566-5232%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Invited contributions ? Irregular | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CURRENT GENE THERAPY] 的評論 | 撰寫評論 |
作者: 千斤雪羽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-17 20:47:50 評論於 Submission success rate: 50.0 Experience sharing: ridiculously slow, still Awaiting Editorial Approval after one month, never get replies to emails, strongly advise against submitting to this journal(0) 讚! | 千斤雪羽 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:47:48 評論於 Title: Submission Column, Article Title, Published Pen Name Content: The full content of the article. Author information: Your real contact address, postal code, name, email address, landline phone, mobile phone, QQ number (indicate QQ name), any other contact information you think is necessary to leave (such as a brief biography(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:39:26 評論於 The time for major revisions of SCI papers, which usually involve additional experiments, is generally not less than two weeks and should not exceed the maximum allowed time of 90 days. Minor revisions typically take 10-20 days. Extension of deadlines can be requested based on individual circumstances(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 09:15:39 評論於 When is the deadline for my submission? Can the deadline be changed? Is the deadline the actual required date by the journal?(0) 讚! | 龙鳞孝礼 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 11:49:51 評論於 What are the contents included in the email for journal submission?(0) 讚! | 北国博达 |
作者: 云来思若 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-05 13:08:11 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: Submitted in November 2013, accepted in March 2014, and published in June. Submitted an article on transgenic stem cells, reviewed by three external reviewers, two responses were made, all opinions were very gentle, accepted three days after response. At that time, the impact factor was still declining after 5.3, now it's over 2. Feeling heartbroken. I remember it seemed to be a bimonthly journal, not many articles were published each year, and the publication fee was around 10,000 RMB, it was SCI-E, overall feeling is okay, graduated with a master's degree that year, felt pretty good overall~(0) 讚! | 云来思若 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us